Inconsistent Country-Wide Reporting of Adverse Drug Reactions to Antimicrobials in Sierra Leone (2017-2021): A

Fawzi Thomas1,2, Onome T Abiri1,2, James P Komeh1,2

  • 1National Pharmacovigilance Center, Pharmacy Board of Sierra Leone, Freetown 02717, Sierra Leone.

Insights

Adverse drug reaction reporting for antimicrobials is inconsistent, delayed, and incomplete. Active reporting and performance targets are crucial for improving patient safety and monitoring drug effects.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Antimicrobial Therapeutics
  • Public Health Monitoring

Background:

  • Adverse drug reactions (ADRs) to antimicrobials pose significant health risks, including severe illness and mortality.
  • Effective monitoring of antimicrobial ADRs is essential for patient safety and public health.
  • This study evaluates the landscape of country-wide antimicrobial ADR reporting and associated patient outcomes.

Purpose of the Study:

  • To assess the completeness, timeliness, and consistency of antimicrobial adverse drug reaction (ADR) reporting.
  • To analyze the types of antimicrobials reported and the outcomes of ADRs.
  • To identify areas for improvement in pharmacovigilance systems for antimicrobials.

Main Methods:

  • A cross-sectional study utilizing individual case safety reports (ICSRs) from a national pharmacovigilance database (VigiFlow) between 2017 and 2021.
  • Analysis of reporting trends, antimicrobial classes, data completeness, reporting delays, and patient outcomes.
  • Categorization of ADRs based on antimicrobial type and affected systems.

Main Results:

  • Inconsistent reporting patterns observed, with peaks during mass drug campaigns and minimal reporting in other years.
  • Antiparasitics dominated reports (90%), with antibiotics, antivirals, and antifungals comprising smaller proportions.
  • Significant reporting delays (median 165 days) and data incompleteness (44% with <75% variables filled) were noted.
  • Gastrointestinal ADRs were most common (60%), with 10 serious ADRs and 18 drug withdrawals recorded. Patient outcomes included recovery (59.5%) and ongoing recovery (35.5%).

Conclusions:

  • Current antimicrobial ADR reporting is characterized by inconsistency, significant delays, and incomplete data.
  • The findings highlight the need for enhanced pharmacovigilance strategies, including active reporting mechanisms.
  • Establishing clear performance targets is recommended to improve the quality and timeliness of ADR reporting for better patient safety.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
243
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
278